BlackRock, Inc. 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
22,779,744 12.000% |
8,038,908 (+54.53%) |
Filing |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
14,740,836 7.800% |
-465,854 (-3.06%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
15,206,690 8.200% |
1,185,398 (+8.45%) |
Filing |
| 2022-03-11 2:13 pm Unchanged |
2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
14,021,292 7.600% |
0 (Unchanged) |
Filing |
| 2022-02-08 5:05 pm Sale |
2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
14,021,292 7.600% |
-745,600 (-5.05%) |
Filing |
| 2021-02-05 08:03 am Purchase |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
BLACKROCK INC BLK |
14,766,892 8.100% |
1,700,689 (+13.02%) |
Filing |